Accunovo Biotechnologies
Chapel Hill
About Accunovo Biotechnologies
Accunovo Biotechnologies will create a detection and treatment agent for better prostate cancer management.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $75.0K
- Last round: Grant (Sep 2022)
Industries & Categories
Health Care, Therapeutics
Canonical: https://fsome.com/organization/accunovo-biotechnologies-157688 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.